188 related articles for article (PubMed ID: 33776563)
1. Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease.
Bronić A; Ferenčak G; Bernat R; Leniček-Krleža J; Dumić J; Dabelić S
J Med Biochem; 2021 Mar; 40(2):138-149. PubMed ID: 33776563
[TBL] [Abstract][Full Text] [Related]
2. The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease.
Bahadori B; Uitz E; Dehchamani D; Pilger E; Renner W
Thromb Res; 2010 Oct; 126(4):350-2. PubMed ID: 20709368
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio.
Uitte de Willige S; Rietveld IM; De Visser MC; Vos HL; Bertina RM
J Thromb Haemost; 2007 Jun; 5(6):1243-9. PubMed ID: 17403086
[TBL] [Abstract][Full Text] [Related]
4. The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
Grünbacher G; Weger W; Marx-Neuhold E; Pilger E; Köppel H; Wascher T; März W; Renner W
Thromb Res; 2007; 121(1):33-6. PubMed ID: 17445871
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.
Theodoraki EV; Nikopensius T; Suhorutsenko J; Peppes V; Fili P; Kolovou G; Papamikos V; Richter D; Zakopoulos N; Krjutskov K; Metspalu A; Dedoussis GV
BMC Med Genet; 2010 Feb; 11():28. PubMed ID: 20167083
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen β chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism.
Klajmon A; Chmiel J; Ząbczyk M; Pociask E; Wypasek E; Malinowski KP; Undas A; Natorska J
Eur J Clin Invest; 2022 Apr; 52(4):e13718. PubMed ID: 34783023
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Bagoly Z; Baráth B; Orbán-Kálmándi R; Szegedi I; Bogáti R; Sarkady F; Csiba L; Katona É
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669007
[TBL] [Abstract][Full Text] [Related]
8. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
9. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen, factor XIII and α
Hoppe B; Schwedler C; Edelmann A; Pistioli A; Poddubnyy D; Burmester GR; Häupl T
Thromb Res; 2020 Jul; 191():90-96. PubMed ID: 32408093
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
Mezei ZA; Bereczky Z; Katona É; Gindele R; Balogh E; Fiatal S; Balogh L; Czuriga I; Ádány R; Édes I; Muszbek L
Int J Mol Sci; 2015 Jan; 16(1):1143-59. PubMed ID: 25569091
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.
Kohler HP; Futers TS; Grant PJ
Thromb Haemost; 1999 Apr; 81(4):511-5. PubMed ID: 10235430
[TBL] [Abstract][Full Text] [Related]
14. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.
Tangurek B; Ozer N; Sayar N; Terzi S; Yilmaz H; Dayi SU; Ciloglu F; Aksu H; Asilturk R; Cagil A
Heart Vessels; 2006 Sep; 21(5):285-90. PubMed ID: 17151815
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
Kardys I; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
Thromb Haemost; 2007 Feb; 97(2):288-95. PubMed ID: 17264959
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen gene variation and ischemic stroke.
Jood K; Danielson J; Ladenvall C; Blomstrand C; Jern C
J Thromb Haemost; 2008 Jun; 6(6):897-904. PubMed ID: 18331453
[TBL] [Abstract][Full Text] [Related]
18. Factor XIII, clot structure, thrombosis.
Bagoly Z; Koncz Z; Hársfalvi J; Muszbek L
Thromb Res; 2012 Mar; 129(3):382-7. PubMed ID: 22197181
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population.
Yang M; Zhu M; Tang L; Zhu H; Lu Y; Xu B; Jiang J; Chen X
Clin Biochem; 2016 Aug; 49(12):873-8. PubMed ID: 27234600
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
Uitte de Willige S; de Visser MC; Houwing-Duistermaat JJ; Rosendaal FR; Vos HL; Bertina RM
Blood; 2005 Dec; 106(13):4176-83. PubMed ID: 16144795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
